Bradmer Pharmaceuticals Inc. Announces Termination of Proposed Reverse Take-Over Transaction With P1 Energy Corp.
15 Luglio 2011 - 10:15PM
Marketwired
Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today
that P1 Energy Corp. and Bradmer have mutually agreed to terminate
the letter of intent between the parties relating to a proposed
reverse take-over transaction. In connection with the termination
of the letter of intent, P1 Energy agreed to pay the costs and
expenses incurred by Bradmer in pursuing the transaction. The
proposed transaction was initially announced by Bradmer on February
10, 2011 and trading of the common shares of Bradmer has been
halted since that date. It is anticipated that the common shares of
Bradmer will resume trading on the NEX Board of the TSX Venture
Exchange on July 19, 2011.
The directors and officers of Bradmer intend to seek out new
opportunities considered to be in the best interests of Bradmer and
its shareholders.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS
THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
Contacts: Bradmer Pharmaceuticals Inc. Paul Van Damme
416.987.6113 pvandamme@bradmerpharma.com
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Bradmer Pharmaceuticals (Venture Exchange Canada (TSXV)): 0 articoli recenti
Più Bradmer Pharmaceuticals Inc. Articoli Notizie